The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience

被引：0
|
作者：
Nasikas, D. [1 ]
Fostira, F. [2 ]
Tsoulos, N. [3 ]
Fokianou, A. [1 ]
Kontogianni, P. [1 ]
Ntasiou, P. [1 ]
Xepapadakis, G. [1 ]
机构：
[1] IASO Hosp, Breast Clin 2, Athens, Greece
[2] NCSR DEMOCRITOS, Mol Diagnost Lab, Athens, Greece
[3] Genekor Med SA, Athens, Greece
来源：
BREAST | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P152
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [41] Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use
    Evelien Schaafsma
    Baoyi Zhang
    Merit Schaafsma
    Chun-Yip Tong
    Lanjing Zhang
    Chao Cheng
    Breast Cancer Research, 23
  • [42] Impact of Oncotype DX testing on ER plus breast cancer treatment and survival in the first decade of use
    Schaafsma, Evelien
    Zhang, Baoyi
    Schaafsma, Merit
    Tong, Chun-Yip
    Zhang, Lanjing
    Cheng, Chao
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [43] Role of clinical judgement in offering adjuvant chemotherapy for Breast Cancer patients in conjunction with tumour profiling test - Oncotype Dx: a single breast unit experience
    Patnam, Varun
    Pushdary, Kamal
    Leaver, Nick
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 59 - 59
  • [44] Cost impact of oncotype Dx® breast cancer assay use in a fully integrated healthcare delivery system
    Carlson, J. J.
    Watanabe, J.
    Boudreau, D.
    CANCER RESEARCH, 2013, 73
  • [45] Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK
    Loncaster, J.
    Armstrong, A.
    Howell, S.
    Wilson, G.
    Welch, R.
    Chittalia, A.
    Valentine, W. J.
    Bundred, N. J.
    EJSO, 2017, 43 (05): : 931 - 937
  • [46] Correlation Between Oncotype Dx Recurrence Score and PREDICT Estimates in Early Breast Cancer: A Single Institution Experience
    Ibrahim, Ezzeldin M.
    Al-Quzi, Bushra A.
    Shaheen, Ahmed Y.
    Kulak, Mohammed H.
    Refae, Ahmed A.
    Al-Foheidi, Meteb E.
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [47] The Oncotype Dx Assay in ER-Positive, HER2-Negative Breast Cancer Patients: A Real Life Experience from a Single Cancer Center
    Thibodeau, Stephane
    Voutsadakis, Ioannis A.
    EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (03) : 163 - 170
  • [48] Impact of Oncotype DX testing on adjuvant treatment decisions in patients with early breast cancer: A single-center study in the United Arab Emirates
    Jaafar, Hassan
    Al Bashir, Mohamed
    Taher, Ali
    Qawasmeh, Khaled
    Jaloudi, Mohammed
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (04) : 354 - 360
  • [49] Impact of Oncotype DX Recurrence Score on Breast Cancer Prognostic Stage Group
    Breaux, Andrea C.
    Sanders, Mary Ann
    Turner, Bradley M.
    Wu, Xiaoyong
    Rai, Shesh N.
    Riley, Elizabeth C.
    MODERN PATHOLOGY, 2018, 31 : 52 - 52
  • [50] Use of Oncotype DX ® testing in nodal positive breast cancer patients: Real-life data from a single center in Munich, Germany
    Kriegmair, A.
    Szeterlak, N.
    Schrodi, S.
    Stoetzer, O.
    Poelcher, M.
    Braun, M.
    CANCER RESEARCH, 2019, 79 (04)
12345